Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
AI 90-DAY FORECAST
NEUTRAL SIGNAL
██.█% Sign up free to reveal

Heartflow, Inc. (HTFL) AI Forecast

Our AI analyzed Heartflow, Inc.. Create a free account to see the 90-day price prediction.

Free account • 30-day free trial

$HTFL Neutral Signal Full forecast available

Heartflow, Inc. (HTFL) AI Stock Price Forecast & Investment Analysis

Heartflow, Inc. Stock Price Chart and Technical Analysis

Loading chart...

Heartflow, Inc. (HTFL) - Comprehensive Stock Analysis & Investment Research

Deep dive into Heartflow, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on June 18, 2026, 7:24 a.m. (UTC)

Heartflow, Inc. Investment Summary

When evaluating whether Heartflow, Inc. (HTFL) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Heartflow, Inc. (HTFL) operates within the Industrial Applications and Services sector, specifically in the Surgical & Medical Instruments & Apparatus industry. . With a market capitalization of $3 billion, the company is a mid-cap stock that typically offers a balance between growth potential and established business operations.

Financial Performance Analysis

Our comprehensive financial analysis covers Heartflow, Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Heartflow, Inc. along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Heartflow, Inc. is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Heartflow, Inc.

Sign Up Free
Corporate Identity

Heartflow, Inc. (Stock Symbol: HTFL) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Surgical & Medical Instruments & Apparatus industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Heartflow, Inc.'s leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Heartflow, Inc....

Sector & Industry Analysis

In-depth sector dynamics and industry context for Heartflow, Inc....

Unlock Full Company Profile

Get complete details about Heartflow, Inc.

Sign Up Free
Revenue & Growth Analysis

Heartflow, Inc. generates annual revenues of $228 million , representing an emerging company in its growth phase.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Heartflow, Inc....

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Heartflow, Inc....

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Heartflow, Inc....

Unlock Financial Analysis

Get complete financial metrics for Heartflow, Inc.

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Heartflow, Inc.'s AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial

30-day free trial • Cancel anytime

Strategic Market Position

Heartflow, Inc. strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace. As a mid-cap company, it occupies an attractive position balancing growth potential with established operations. Mid-caps often represent the 'sweet spot' for investors seeking companies that have proven their business models but still have meaningful runway for expansion. These companies are large enough to have competitive advantages but nimble enough to adapt quickly to market changes.

Industry Competitive Landscape

Heartflow, Inc. competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency

The company currently shows negative free cash flow of $-91 million . Negative free cash flow may reflect heavy investment in growth, working capital needs, or operational challenges. This is common for high-growth companies investing aggressively but warrants attention for mature businesses.

Margin & Pricing Power Analysis

The company maintains a 75.5% gross margin which reflects exceptional pricing power and/or an asset-light business model. Gross margins at this level are typically seen in software, pharmaceuticals, or luxury goods companies where the cost of incremental production is minimal relative to selling prices. Such margins indicate significant competitive advantages protecting the company from price-based competition.

Operating margin of -31.6% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. Operating margin compression relative to gross margin suggests high operating expenses that may warrant efficiency improvements or reflect necessary growth investments.

Asset Utilization Efficiency

Asset turnover ratio of 0.66x indicates moderate asset turnover common in capital-intensive industries such as utilities, real estate, or heavy manufacturing. Lower turnover in these sectors is expected due to the significant infrastructure required for operations.

Financial Strength & Leverage

Current ratio of 5.57 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.

Heartflow, Inc. (HTFL) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Heartflow, Inc. stock analysis.

Deep dive into Heartflow, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Heartflow, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Heartflow, Inc.:

P/B Ratio 9.90x
Market Cap $2.83B
EPS $-5.84
Book Value/Share $3.32
Revenue/Share $2.66
FCF/Share $-1.06
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Heartflow, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Heartflow, Inc.: An ROE of -58.2% indicates room for improvement in shareholder value creation.

ROE -58.2%
ROA -48.3%
ROIC -17.9%
Gross Margin 75.5%
Operating Margin -31.6%
Net Margin -95.7%
EBT Margin -21.0%
Tax Rate -0.7%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Heartflow, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Heartflow, Inc.: A current ratio of 5.57 indicates strong liquidity.

Current Ratio 5.57x
D/E Ratio 0.20x
Financial Leverage 1.20x
Interest Coverage -8.2x
Working Capital $174M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Heartflow, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Heartflow, Inc.: Free cash flow of $-91M indicates cash challenges that need attention.

Operating Cash Flow -$162M
Free Cash Flow -$91M
Capital Spending $71M
FCF/Sales -39.8%
CapEx/Sales 31.0%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Heartflow, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Heartflow, Inc.: An asset turnover of 0.66x suggests room for improvement in asset utilization.

Asset Turnover 0.66x
Receivables Turnover 6.4x
Fixed Assets Turnover 23.3x
Days Sales Outstanding 57 days
Payables Period 49 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Heartflow, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Heartflow, Inc.: With annual revenue of $228M, Heartflow, Inc. demonstrates solid business size.

Income Statement
Total Revenue $228M
Operating Income -$54M
Net Income -$166M
R&D Expense $60M
SG&A Expense $126M
Cost of Goods Sold $43M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 212%
Cash & Short-term Investments 20%
Total Liabilities 58%
Short-term Debt 32%
Accounts Receivable 36%
Dividend & Shareholder Information
Shares Outstanding 86M
Growth Metrics (YoY)
Net Income Growth -95.7%
EPS Growth -17.8%

Latest Heartflow, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Heartflow, Inc. (HTFL) stock price and investment outlook.

source: Yahoo Finance

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

source: Seeking Alpha

Good day, everyone, and welcome to HeartFlow Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note, this conference is being recorded. I would now like to turn the ...

More news available

Sign up free to read all 10 news articles and stay updated on market developments.

Sign Up Free to Read More

Heartflow, Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Heartflow, Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
Adagio Medical Holdings, Inc. ADGM ██% $16M x 2.7x
Aethlon Medical Inc AEMD ██% $5M x 0.9x
Acutus Medical, Inc. AFIB ██% $0.00M 0.0x -0.4x
Allurion Technologies, Inc. ALUR ██% $9M x x
Autonomix Medical, Inc. AMIX ██% $4M x 0.8x
Angiodynamics Inc ANGO ██% $489M x 2.8x
Anika Therapeutics, Inc. ANIK ██% $190M x 1.4x
Artivion, Inc. AORT ██% $1.02B 87.2x 2.3x
Apyx Medical Corp APYX ██% $176M x 13.7x
Accuray Inc ARAY ██% $41M x 1.0x
Alphatec Holdings, Inc. ATEC ██% $1.27B x x
Atricure, Inc. ATRC ██% $1.37B x 2.8x
Nuo Therapeutics, Inc. AURX ██% $47M x x
Avita Medical, Inc. AVHHL ██% $22M x x
Baxter International Inc BAX ██% $9.99B x 1.7x
Beta Bionics, Inc. BBNX ██% $588M x 2.2x
Becton Dickinson & Co BDX ██% $39.02B 34.3x 1.6x
Heartbeam, Inc. BEAT ██% $40M x 62.6x
Bluejay Diagnostics, Inc. BJDX ██% $5M x 1.1x
Boston Scientific Corp BSX ██% $66.75B 18.7x 2.6x
Biotricity Inc. BTCY ██% $4M x x
Bioventus Inc. BVS ██% $575M 20.2x 3.0x
Brainsway Ltd. BWAY ██% $578M x x
Carlsmed, Inc. CARL ██% $271M x 2.9x
Cerus Corp CERS ██% $499M x 7.4x
Clearpoint Neuro, Inc. CLPT ██% $504M x 26.8x
Co-Diagnostics, Inc. CODX ██% $12M x 0.8x
Cytosorbents Corp CTSO ██% $30M x 13.6x
Cvrx, Inc. CVRX ██% $128M x 4.4x
Delcath Systems, Inc. DCTH ██% $411M 732.9x 3.7x
Dih Holding Us, Inc. DHAI ██% $70K x -0.3x
Dariohealth Corp. DRIO ██% $52M x 0.8x
Alpha Tau Medical Ltd. DRTS ██% $846M x 11.0x
Dexcom Inc DXCM ██% $27.49B 29.5x 9.3x
Dynatronics Corp DYNT ██% $540K -0.2x 0.2x
Dynatronics Corp DYNTQ ██% $0.00M x 0.0x
Ebr Systems, Inc. EBRCZ ██% $84M x 8.8x
Encision Inc ECIA ██% $3M x 1.8x
Embecta Corp. EMBC ██% $183M 1.6x x
Electromedical Technologies, Inc EMED ██% $750K x x
Femasys Inc FEMY ██% $13M x 1.7x
Family Office Of America, Inc. FOFA ██% $36M 231.9x 37.6x
Glucotrack, Inc. GCTK ██% $2M x x
Global Innovative Platforms Inc. GIPL ██% $170K x 0.3x
Glaukos Corp GKOS ██% $7.44B x 11.1x
Globus Medical Inc GMED ██% $10.21B 17.4x 2.2x
Fractyl Health, Inc. GUTS ██% $135M x 6.3x
Haemonetics Corp HAE ██% $3.29B 33.8x 4.1x
Harvard Apparatus Regenerative Technology, Inc. HRGN ██% $19M x 204.5x
Heartflow, Inc. HTFL ██% $2.83B x 9.9x
Integra Lifesciences Holdings Corp IART ██% $1.32B x 1.3x
Icecure Medical Ltd. ICCM ██% $18M x 2.0x
Seastar Medical Holding Corp ICU ██% $88M -1.1x 7.7x
Icu Medical Inc/De ICUI ██% $3.45B 74.4x 1.6x
Interpace Biosciences, Inc. IDXG ██% $46M 1.9x 2.0x
Qtrex Quantum Ltd. IINN ██% $132M x 56.7x
Inspira Technologies Oxy B.H.N. Ltd IINNW ██% $7M x 1.5x
Intelligent Bio Solutions Inc. INBS ██% $5M x 0.6x
Infusystem Holdings, Inc INFU ██% $169M 30.5x 3.0x
Inspire Medical Systems, Inc. INSP ██% $1.18B 9.0x 1.5x
Iradimed Corp IRMD ██% $1.16B 49.3x 11.8x
Irhythm Holdings, Inc. IRTC ██% $3.34B x 20.7x
Invo Fertility, Inc. IVF ██% $3M x 0.5x
Orthopediatrics Corp KIDS ██% $430M x 1.3x
Kestra Medical Technologies, Ltd. KMTS ██% $1.11B x 3.9x
Koru Medical Systems, Inc. KRMD ██% $179M x 10.6x
Lemaitre Vascular Inc LMAT ██% $2.11B 33.8x 5.2x
Lensar, Inc. LNSR ██% $76M 2.6x 7.0x
Lucid Diagnostics Inc. LUCD ██% $188M x 46.9x
Pulmonx Corp LUNG ██% $53M x 1.2x
Lyra Therapeutics, Inc. LYRA ██% $1M x x
Microbot Medical Inc. MBOT ██% $126M x 1.7x
Mountain Crest Acquisition Corp. V MCAG ██% $37M x x
Mountain Crest Acquisition Corp. V MCAGU ██% $31M x -9.9x
Spectral Ai, Inc. MDAI ██% $58M x x
Medline Inc. MDLN ██% $66.09B 78.9x 5.9x
Medinotec Inc. MDNC ██% $59M 74.0x 10.3x
Mimedx Group, Inc. MDXG ██% $549M 17.9x 2.3x
Monogram Technologies Inc. MGRM ██% $217M -10.7x 25.1x
Meihua International Medical Technologies Co., Ltd. MHUA ██% $151M x 0.9x
3m Co MMM ██% $84.81B 30.4x 26.0x
Merit Medical Systems Inc MMSI ██% $4.04B 29.0x 2.5x
Modular Medical, Inc. MODD ██% $25M x 4.3x
Nephros Inc NEPH ██% $35M 44.6x 3.2x
Neuroone Medical Technologies Corp NMTC ██% $28M x 5.5x
Neuropace Inc NPCE ██% $526M x 36.4x
Inspiremd, Inc. NSPR ██% $33M x 0.8x
Nu-Med Plus, Inc. NUMD ██% $790K x x
Novocure Ltd NVCR ██% $2.03B x 6.1x
Envveno Medical Corp NVNO ██% $7M x 0.3x
Nexgel, Inc. NXGL ██% $4M x 1.1x
Nyxoah Sa NYXH ██% $167M x x
Orchestra Biomed Holdings, Inc. OBIO ██% $226M x 5.5x
Odyssey Health, Inc. ODYY ██% $1M x x
Orthofix Medical Inc. OFIX ██% $380M x 0.9x
Osr Health, Inc. OSRH ██% $13M x 0.1x
Orasure Technologies Inc OSUR ██% $300M x 1.0x
Pavmed Inc. PAVM ██% $36M x 0.9x
Pro Dex Inc PDEX ██% $197M 16.4x 4.4x
Penumbra Inc PEN ██% $12.51B 73.1x 8.5x
Petvivo Holdings, Inc. PETV ██% $29M x 8.7x
Profusa, Inc. PFSA ██% $1M x x
Polyrizon Ltd. PLRZ ██% $21M x 1.0x
Pulse Biosciences, Inc. PLSE ██% $1.71B x 25.8x
Picard Medical, Inc. PMI ██% $16M x x
Insulet Corp PODD ██% $10.34B 34.1x 7.9x
Procept Biorobotics Corp PRCT ██% $1.26B x 3.6x
Premier Air Charter Holdings Inc. PREM ██% $2M x 0.6x
Profound Medical Corp. PROF ██% $245M x 4.1x
Plus Therapeutics, Inc. PSTV ██% $31M x 2.6x
Polypid Ltd. PYPD ██% $85M x 7.7x
Qtrex Quantum Ltd. QTEX ██% $94M x 40.5x
Avita Medical, Inc. RCEL ██% $121M x x
Vivos Inc RDGL ██% $29M x 10.9x
Resmed Inc RMD ██% $27.33B 18.0x 4.2x
Resmed Inc RSMDF ██% $3.82B 2.7x 0.6x
Retinalgenix Technologies Inc. RTGN ██% $75M x x
Retractable Technologies Inc RVP ██% $20M x 0.3x
Sight Sciences, Inc. SGHT ██% $271M x 5.0x
Si-Bone, Inc. SIBN ██% $676M x 3.8x
Sigyn Therapeutics, Inc. SIGY ██% $60K x x
Sintx Technologies, Inc. SINT ██% $13M x 14.8x
Skinhealth Systems Inc. SKIN ██% $84M x 1.5x
Sonoma Pharmaceuticals, Inc. SNOA ██% $4M x 1.2x
Sanuwave Health, Inc. SNWV ██% $73M 4.6x 39.8x
Solventum Corp SOLV ██% $13.03B 9.1x 2.6x
Sensus Healthcare, Inc. SRTS ██% $45M x 1.0x
Ss Innovations International, Inc. SSII ██% $694M x 12.7x
Strata Skin Sciences, Inc. SSKN ██% $880K x 0.3x
Neuronetics, Inc. STIM ██% $84M x 6.3x
Stimcell Energetics Inc. STME ██% $7M x x
Skyai, Inc. STSS ██% $61M x 0.3x
Stevanato Group S.P.A. STVN ██% $4.51B x x
Stryker Corp SYK ██% $119.06B 35.7x 5.2x
Tactile Systems Technology Inc TCMD ██% $602M 29.7x 2.8x
Tela Bio, Inc. TELA ██% $38M x x
Teleflex Inc TFX ██% $5.66B x 1.8x
Trisalus Life Sciences, Inc. TLSI ██% $241M x 18.8x
Trisalus Life Sciences, Inc. TLSIW ██% $62M x -1.9x
Treace Medical Concepts, Inc. TMCI ██% $268M x 3.5x
Tandem Diabetes Care Inc TNDM ██% $1.10B x 8.3x
Tenon Medical, Inc. TNON ██% $7M x 3.6x
T2 Biosystems, Inc. TTOO ██% $210K 0.0x -0.3x
Ufp Technologies Inc UFPT ██% $1.82B 26.5x 4.1x
Qhslab, Inc. USAQ ██% $4M 8.5x 2.4x
Utah Medical Products Inc UTMD ██% $213M 19.7x 1.8x
Venus Concept Inc. VERO ██% $580K x 0.2x
Catheter Precision, Inc. VTAK ██% $3M x 0.3x
Vivos Therapeutics, Inc. VVOS ██% $8M x x
Vycor Medical Inc VYCO ██% $2M x x
West Pharmaceutical Services Inc WST ██% $23.18B 42.7x 7.8x
Beyond Air, Inc. XAIR ██% $4M x 0.5x
Xtant Medical Holdings, Inc. XTNT ██% $62M 33.8x 1.3x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Heartflow, Inc. Stock Forecast

How accurate are Heartflow, Inc. stock predictions?

Our AI model shows a 3% Spearman correlation coefficient for HTFL predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Heartflow, Inc. stock price forecasts?

Our analysis considers Heartflow, Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Heartflow, Inc. a good investment in 2025?

Based on our AI analysis, Heartflow, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Heartflow, Inc. forecasts updated?

Heartflow, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want a simpler view of Heartflow, Inc.?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...